Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
1.230
+0.070 (6.03%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Sonoma Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 21.92 | 19.53 | 14.29 | 12.74 | 13.27 | 12.63 |
Revenue Growth | 47.00% | 36.68% | 12.20% | -4.05% | 5.10% | -32.21% |
Gross Profit Gross Profit Growth | 8.53 | 7.42 | 5.47 | 4.75 | 4.48 | 3.99 |
Operating Income Operating Income Growth | -1.41 | -2.46 | -3.71 | -4.7 | -4.57 | -5.89 |
Net Income Net Income Growth | -2.26 | -3.18 | -3.46 | -4.84 | -5.15 | -5.09 |
Earnings Per Share EPS Growth | -1.01 | -1.89 | -2.79 | -10.63 | -30.35 | -38.34 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
United States United States Growth | 7.1 | 5.67 | 2.61 | 3.06 | 3.43 | 3.81 |
Europe Europe Growth | 7.4 | 6.9 | 5.52 | 4.78 | 4.05 | 3.41 |
Asia Asia Growth | 3.15 | 2.9 | 2.32 | 2.3 | 2.45 | 2.35 |
Latin America Latin America Growth | 2.44 | 2.37 | 2.96 | 1.73 | 2.38 | 2.1 |
Rest of The World Rest of The World Growth | 1.84 | 1.68 | 0.88 | 0.87 | 0.96 | 0.97 |
Total Total Growth | 21.92 | 19.53 | 14.29 | 12.74 | 13.27 | 12.63 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5.34 | 2.4 | 5.37 | 3.13 | 3.82 | 7.4 |
Total Debt Total Debt Growth | 0.74 | 0.84 | 0.31 | 0.61 | 0.85 | 1.37 |
Net Cash (Debt) Net Cash Growth | 4.6 | 1.56 | 5.07 | 2.52 | 2.97 | 6.03 |
Net Cash Growth | 56.96% | -69.28% | 101.15% | -15.18% | -50.72% | 290.23% |
Net Cash Per Share Net Cash Per Share Growth | 2.06 | 0.92 | 4.08 | 5.54 | 17.51 | 45.45 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -2.57 | -3.93 | -0.09 | -2.4 | -6.15 | -4.25 |
Capital Expenditures CapEx Growth | -0.09 | -0.19 | -0.08 | -0 | -0.27 | -0.14 |
Free Cash Flow Free Cash Flow Growth | -2.66 | -4.13 | -0.17 | -2.4 | -6.42 | -4.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 38.91% | 37.97% | 38.25% | 37.26% | 33.73% | 31.62% |
Operating Margin | -6.41% | -12.60% | -25.97% | -36.91% | -34.43% | -46.62% |
Pretax Margin | -11.44% | -17.51% | -20.35% | -39.51% | -39.06% | -42.90% |
Profit Margin | -10.33% | -16.26% | -24.20% | -37.97% | -38.81% | -40.28% |
FCF Margin | -12.11% | -21.12% | -1.18% | -18.85% | -48.38% | -34.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 11.93 | 11.93 | 11.93 | 11.93 | 11.93 |
PS Ratio | 0.27 | 0.19 | 0.25 | 0.20 | 0.34 | 0.98 |